Aarkstore Enterprise Market of Paclitaxel Injection in China

FOR IMMEDIATE RELEASE
Mumabi, Maharashtra, India, Republic of (Free-Press-Release.com) June 11, 2011 -- Nowadays, paclitaxel injection has been widely used to cure cancers like non-small cell lung cancer, breast cancer, and ovarian cancer, etc. Besides, paclitaxel injection has become one of the best selling anticancer drugs in the world. The paclitaxel injection production values had reached USD67.21 million for China in 2009, accounting for 10% of total in world. China has become one of the most important consumption markets in the world.

Chinese paclitaxel injection industry has witnessed significant development from 2005`2009. On the one hands, since 2005, Chinafs government has issued a series of policies related to Chinafs pharmaceutical industry like healthcare reform. What they effect the paclitaxel injection industry? On the other hand, paclitaxel injection has become the second largest market share in natural anticancer drugs in China, thanks to its good clinical effect and less side effect. What is the current production and consumption situation in China?

For China paclitaxel injection manufacturers, active pharmaceutical ingredient (paclitaxel APIs) plays an important role for them expend. Owing to the forbidden for the develop of natural yew and the development for planting yew, price of APIs has declined gradually, thus pushing down the price of paclitaxel injection price and get less profit. Besides, by the end of Jun. 2010, Chinese government has adjusted export tax rebate rate of paclitaxel injection. How the paclitaxel APIs and paclitaxel injection manufactures replied for this change? In 2009, Sichuan Jiufeng Pharmaceutical Nowadays, paclitaxel injection has been widely used to cure cancers like non-small cell lung cancer, breast cancer, and ovarian cancer, etc. Besides, paclitaxel injection has become one of the best selling anticancer drugs in the world. The paclitaxel injection production values had reached USD67.21 million for China in 2009, accounting for 10% of total in world. China has become one of the most important consumption markets in the world.

Chinese paclitaxel injection industry has witnessed significant development from 2005`2009. On the one hands, since 2005, Chinafs government has issued a series of policies related to Chinafs pharmaceutical industry like healthcare reform. How do they influence the paclitaxel injection industry? On the other hand, paclitaxel injection has enjoyed the second largest market share in natural anticancer drugs in China, thanks to its good clinical effect and less side effect. What is the current production and consumption situation in China?

For more information please visit

http://www.aarkstore.com/reports/Market-of-Paclitaxel-Injection-in-China-55025.html

Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com
From:Aarkstore Enterprise

More Reports

Production, Market and Manufacturing Cost of Sugar Alcohols in China
Production and Market of Gum Rosin in China
Metalaxyl Survey in China
Nicosulfuron Survey in China
Future Prosepct of Genetically Modified Crops
Reserch on CNY Exchange Rate
Research on Loan and Interest in China
Future of PVC Industry in China

     Aarkstore Enterprise     business     market     report     research